AIDSmeds.com newsletter
<http://www.aidsmeds.com/>


*Special Report*
Lessons from a Vaccine Failure
<http://www.aidsmeds.com/articles/HIV_vaccine_Merck_2042_13172.shtml>
The premature closing of a large clinical trial testing Merck's
preventive HIV vaccine is hardly good news. But there's always
something to be learned from failure.


*Treatment News from AIDSmeds.com*

October 09, 2007

HIV Treatments Protective Against Brain Damage
<http://www.aidsmeds.com/articles/hiv_brain_dementia_1667_13181.shtml>
A study published in the October 9 issue of the journal Neurology
has found that highly active antiretroviral therapy (HAART) may
protect the brain from damage by HIV.


October 08, 2007

Better Quality of Life for People With HIV Who Quit Smoking
<http://www.aidsmeds.com/articles/1667_13173.shtml>
A small study published in the September 2007 issue of AIDS Patient
Care and STDs reports that people's HIV-related symptoms and
quality of life can improve when they quit smoking.


October 04, 2007

Needle-Free Fuzeon Abandoned for Now
<http://www.aidsmeds.com/articles/hiv_fuzeon_biojector_1667_13159.shtml>
Roche and Trimeris, Inc. have announced that they will no longer
pursue government approval to market a needle-free injection device
for use with their entry inhibitor, Fuzeon (enfuvirtide).


October 03, 2007

Key Protein Blunts Immune System's Power to Fight HIV
<http://www.aidsmeds.com/articles/hiv_immune_ctla4_1667_13152.shtml>
Researchers at the Partners AIDS Research Center at Massachusetts
General Hospital announce that they have uncovered a mechanism that
suppresses the immune system's ability to control HIV, possibly
resulting in a new target for HIV treatment.



Copyright 2007 Smart + Strong, 500 Fifth Avenue, Suite 320, New York,
NY 10110. All rights reserved.